Similar articles

• Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.

  Bartlett J, Predazzi IM, Williams SM, Bush WS, Kim Y, Havas S, Toth PP, Fazio S, Miller M. Bartlett J, et al. Circ Cardiovasc Qual Outcomes. 2016 May;9(3):206-212. doi: 10.1161/CIRCOUTCOMES.115.002436. Epub 2016 May 10. Circ Cardiovasc Qual Outcomes. 2016. PMID: 27166203 Free PMC article.
• Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.

  Rosenson RS. Rosenson RS. Am Heart J. 2006 Mar;151(3):556-63. doi: 10.1016/j.ahj.2005.03.049. Am Heart J. 2006. PMID: 16504615
• Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

  Cziraky MJ, Watson KE, Talbert RL. Cziraky MJ, et al. J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. J Manag Care Pharm. 2008. PMID: 19891279 Review.
• Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).

  Spinler SA, Cziraky MJ, Willey VJ, Tang F, Maddox TM, Thomas T, Dueñas GG, Virani SS; NCDR. Spinler SA, et al. Am J Cardiol. 2015 Aug 15;116(4):547-53. doi: 10.1016/j.amjcard.2015.05.011. Epub 2015 May 21. Am J Cardiol. 2015. PMID: 26089010
• Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment.

  Carr SS, Hooper AJ, Sullivan DR, Burnett JR. Carr SS, et al. Pathology. 2019 Feb;51(2):148-154. doi: 10.1016/j.pathol.2018.11.006. Epub 2018 Dec 27. Pathology. 2019. PMID: 30595507 Review.